Peptide Degradation

Peptide degradation refers to the full set of chemical, enzymatic and physical reactions that alter molecular structure and degrade purity, biological activity and experimental reproducibility. Any rigorous research study requires complete mastery of these mechanisms — a peptide degraded to 80% generates invalid data.

Several major pathways exist. (1) Chemical degradation: hydrolysis of peptide bonds (especially Asp-Pro, Asp-X), oxidation (Met, Cys, Trp), deamidation (Asn, Gln), racemization (α-carbon inversion), β-elimination, isomerization. (2) Enzymatic degradation: cleavage by contaminating proteases (residual traces of trypsin, chymotrypsin, papain in non-sterile environments), particularly active in solution at physiological pH. (3) Physical degradation: aggregation, precipitation, adsorption onto vial walls (borosilicate glass, non-siliconized plastics), denaturation from repeated freeze-thaw cycles, mechanical stress (aggressive vortexing).

Each peptide class has its signature. Met-rich peptides (TB-500, BPC-157) oxidize. Peptides with Asn-Gly motifs (semaglutide) deamidate. Long hydrophobic peptides (retatrutide, tirzepatide) aggregate. Cyclic disulfide peptides (oxytocin, somatostatin) are redox-sensitive.

Monitoring tools include analytical HPLC (relative purity), LC-MS (parasitic masses), SEC (size exclusion for aggregates), UV spectroscopy (intact Trp/Tyr chromophores), cellular bioactivity assays.

Prevention rests on five pillars: (1) storage at -20 °C or -80 °C lyophilized under inert atmosphere, (2) reconstitution immediately before use with sterile bacteriostatic water, (3) immediate aliquoting to avoid freeze-thaw cycles, (4) handling in controlled environment (hood, gloves, dedicated pipettes), (5) rigorous documentation of receipt, opening and use dates. A disciplined protocol (freezer, protection from light, few openings) markedly slows these losses.

Peptide degradation pathways in aqueous solution are multiple and strongly depend on pH, temperature, light and oxygen presence. Most frequent reactions are: (1) peptide bond hydrolysis accelerated in acidic or basic medium (half-life at pH 2 or pH 12 of a few days vs months at pH 6-7); (2) deamidation of Asn and Gln residues to Asp and Glu (ΔM = +1 Da), accelerated above pH 8; (3) oxidation of Met and Cys residues to Met-sulfoxide (ΔM = +16 Da) and Cys-disulfide (ΔM = -2 Da per pair); (4) racemisation of chiral residues from L- to D- during prolonged storage or heating; (5) aggregation β-sheet oligomer or amyloid fibril formation (visible by ThT fluorescence or DLS).

Degradation product detection requires an analytical combination: RP-HPLC with UV detection at 214 nm (peptide bond) and 280 nm (Trp, Tyr) identifies impurity peaks, ESI-HRMS confirms characteristic ΔM of modifications, SEC-HPLC quantifies high-mass aggregates, CD verifies native secondary structure preservation. A compliant RUO research peptide shows RP-HPLC purity ≥ 98% with identification of each > 0.1% impurity. Recommended storage conditions (-20°C lyophilised, 2-8°C reconstituted, amber vial) minimise all these degradation pathways.